FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4
Lana McClements(University of Technology Sydney), Tracy Robson(Queen's University Belfast)
Cited by 67
Related Papers
The Concise Guide to PHARMACOLOGY 2023/24: Enzymes
|British Journal of Pharmacology|2023|442
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes
|British Journal of Pharmacology|2021|384